Therapy of Relapsed or Refractory Aggressive Lymphomas Treatment approaches to non-Hodgkin’s lymphoma in elderly patients Larry W. Kwak, M.D., Ph.D. Chairman, Department…

1. The Chronic Lymphocytic LeukemiaThe Chronic Lymphocytic Leukemia (CLL)(CLL) Dr.manoj toshniwalDr.manoj toshniwal 2. • B-CLL is a neoplastic disease characterized by…

1. Best approach to newlydiagnosed multiple myelomaElisabet Manasanch M.D., M.H.Sc.Assistant Professor, Department of Lymphoma/MyelomaDivision of Cancer Medicine 2. DisclosuresNothing…

1. Tumor Board Multiple Myeloma Ranjita Pallavi, MD Medicine Department 2. Patient Course at Bellevue Patient presented with obstructive jaundice at an outside hospital.…

Autologous stem cell transplantation for multiple myeloma: history and future Chihiro SHIMAZAKI1 Over the last decade, high-dose therapy supported by autologous stem cell

Elotuzumab for the treatment of multiple myelomaREVIEW Open Access Elotuzumab for the treatment of multiple myeloma Yucai Wang1†, Larysa Sanchez1†, David S.

13 (CC2015).inddM ultiple myeloma (MM) is caused by tumori- genically transformed plasma cells, a termi- nally differentiated form of B lymphocytes, and is char- acterized